More than one in 10 women may experience serious complications, such as hemorrhaging or severe infection, from medication abortions, according to a large-scale study published Monday.
The new study, published by the anti-abortion Ethics and Public Policy Center, examined insurance claims data from over 865,000 mifepristone prescriptions from 2017 to 2023 and found that nearly 11% of women experience a potentially life-threatening complication within 45 days of a mifepristone abortion.
That’s about 22 times higher than the less than 0.5% complication rate from clinical trials cited by the Food and Drug Administration and Danco Laboratories, the manufacturers of the abortion medication Mifeprex.
Trending: DEVELOPING: ‘Nationwide Outage’ Allegedly Hits Major American Bank
In one of the largest real-world studies on mifepristone to date, researchers analyzed insurance codes for nearly 700,000 women across the country over six
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!